Merck Group Calls 2023 “Transitional Year”
Merck Group’s Sales declined, especially in Life Science due to Covid-19 and semiconductor slowdown, but Healthcare saw growth.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
